Skip to main content
Clinical Trials/NCT01585948
NCT01585948
Completed
N/A

The Role of Newer and Traditional Risk Factors in the Development, Extent and Manifestation of Coronary Artery Disease

University of Ioannina1 site in 1 country1,104 target enrollmentNovember 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Patients Undergoing Coronary Angiography
Sponsor
University of Ioannina
Enrollment
1104
Locations
1
Primary Endpoint
The incidence and extent of coronary artery disease between diabetics and non-diabetic patients.
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

In the present study the investigators will measure the extent of coronary artery disease via coronary angiography and the correlating risk factors.

Detailed Description

In the present study the investigators will examine the risk factors determining the development, extent and the manifestation of coronary artery disease. The study will recruit patients undergoing coronary angiography for clinical purposes.

Registry
clinicaltrials.gov
Start Date
November 2009
End Date
March 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

MICHALIS LAMPROS

Professor of Cardiology, Medical School, University of Ioannina

University of Ioannina

Eligibility Criteria

Inclusion Criteria

  • Any subject eligible for coronary angiography with or without known CV disease for clinical reasons.

Exclusion Criteria

  • Patients revascularized in the past, with either coronary artery bypass grafting or percutaneous coronary intervention, will be excluded from the study since it is not possible to describe the extent of CAD in these patients.
  • Moderate or severe aortic stenosis.

Outcomes

Primary Outcomes

The incidence and extent of coronary artery disease between diabetics and non-diabetic patients.

Time Frame: Up to four years on average.

We will investigate the incidence, extent and clinical manifestation of coronary artery disease in diabetics and non-diabetics undergoing coronary angiography for clinical reasons.

Secondary Outcomes

  • TCF7L2 gene polymorphims and the incidence and extent of coronary artery disease.(Within a maximum period of 4 years.)
  • The incidence and extent of coronary artery disease via coronary angiography scores and related biochemical and demographical risk factors.(Up to 4 years on average.)
  • The incidence, extent and clinical manifestation of coronary artery disease and the circulating levels of hs-CRP, adipokines and RAGEs.(Up to 4 years on average.)

Study Sites (1)

Loading locations...

Similar Trials